Overview of Single-Use Biomanufacturing Techniques and Trends, Outlining the Importance of Reactive Biomanufacturing
NEEDHAM, MA--(Marketwired - June 08, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, provides the life science sciences community the report entitled: Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system which focuses on the need for a more reactive and dynamic biomanufacturing approach than is the current industry standard.
Biomanufacturing is common practice in the life sciences industry and has been continually developed and improved for the last two decades. However, as blockbuster drugs reach the end of their patents, treatment is evolving to become more patient-centric and personalized. The mapping of the human genome has allowed for sophisticated and effective new genetic markers and diagnostic methods to be developed, meaning that personalized medicine is becoming a reality. This has a direct impact on manufacturing, with long-term expected production paradigm shifts in the shape of near-patient manufacturing.
In addition to covering background information on biomanufacturing and capacity approaches, the Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system report will highlight several technologies, methodologies, and business strategies that can be implemented to improve the capacity and flexibility of biomanufacturing.
Included in this Report:
For more information on these reports visit: InsightPharmaReports.com/Biomanufacturing-Capacity-Strategies-Report
About Insight Pharma Reports (www.insightpharmareports.com)
Insight Pharma Reports, a division of Healthtech Publishing, is the premier life sciences information provider offering unparalleled coverage of key issues in drug discovery and development. The reports are used by leading pharmaceutical, biotech, diagnostic, and other life science companies to keep abreast of the latest developments in pharmaceutical R&D and their potential applications and business impacts. The reports are written by experts in consulting and industry, and are supported by hundreds of hours of primary and secondary research. Insight Pharma Reports provide comprehensive coverage of salient issues in a concise, well-organized format.
About Healthtech Publishing
(www.healthtechpublishing.com)
Healthtech Publishing, a division of Cambridge Healthtech Institute, provides the life science communities with business critical intelligence through research reports and digital news, helping decision makers to gain competitive advantage and make strategic decisions. Our portfolio consists of Insight Pharma Reports' vast research reports collection and three niche digital subscription products: Bio-IT World, Clinical Informatics News and Diagnostics World.
Contact Information:
For more information:
Daniel Miller
Insight Pharma Reports
dmiller@insightpharmareports.com